
Please try another search
On Wednesday, RBC Capital Markets adjusted its stance on BioMerieux (BIM:FP) (OTC:BMXMF), downgrading the stock from Outperform to Sector Perform and reducing the price target to €125 from the...
Investing.com -- bioMérieux on Thursday reported 12.7% organic sales growth in the first quarter of 2025, but shares fell over 4% as currency headwinds widened and sales in China fell. Revenue for the...
Biomerieux (EPA:BIOX) SA reported its second-half fiscal year 2024 results on Friday, posting a strong quarter largely driven by its Molecular business, with sales surpassing consensus...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review